| Dr Ilene Chiu, MD | |
|
600 S Main St, Fort Worth, TX 76104-2410 | |
| (817) 882-2400 | |
| Not Available |
| Full Name | Dr Ilene Chiu |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 14 Years |
| Location | 600 S Main St, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003127259 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 550053 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
U.S. Senator John McCain, 80, is on the way to recovery after undergoing a craniotomy operation to remove a blood clot from his brain. According to a statement released by the Mayo Clinic where he is being treated, Senator McCain underwent a routine physical examination followed by which the blood clot was detected in his brain. The surgery to remove the blood clot from above his left eye was performed at the Mayo Clinic Hospital in Phoenix on Friday 14th of July.
Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.
After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.
WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that an Investigational New Drug (IND) application for WuXi MedImmune's novel anti-IL6 monoclonal antibody for rheumatoid arthritis has been accepted for review by the China Food and Drug Administration.
› Verified 8 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
U.S. Senator John McCain, 80, is on the way to recovery after undergoing a craniotomy operation to remove a blood clot from his brain. According to a statement released by the Mayo Clinic where he is being treated, Senator McCain underwent a routine physical examination followed by which the blood clot was detected in his brain. The surgery to remove the blood clot from above his left eye was performed at the Mayo Clinic Hospital in Phoenix on Friday 14th of July.
Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.
After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.
WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that an Investigational New Drug (IND) application for WuXi MedImmune's novel anti-IL6 monoclonal antibody for rheumatoid arthritis has been accepted for review by the China Food and Drug Administration.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ilene Chiu, MD 5323 Harry Hines Blvd # Na102, Dallas, TX 75390-7208 Ph: () - | Dr Ilene Chiu, MD 600 S Main St, Fort Worth, TX 76104-2410 Ph: (817) 882-2400 |
News Archive
U.S. Senator John McCain, 80, is on the way to recovery after undergoing a craniotomy operation to remove a blood clot from his brain. According to a statement released by the Mayo Clinic where he is being treated, Senator McCain underwent a routine physical examination followed by which the blood clot was detected in his brain. The surgery to remove the blood clot from above his left eye was performed at the Mayo Clinic Hospital in Phoenix on Friday 14th of July.
Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.
After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.
WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that an Investigational New Drug (IND) application for WuXi MedImmune's novel anti-IL6 monoclonal antibody for rheumatoid arthritis has been accepted for review by the China Food and Drug Administration.
› Verified 8 days ago
Dr. Lisa Mckay Buckmiller, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 901 7th Ave, Fort Worth, TX 76104 Phone: 682-885-6850 Fax: 682-885-6799 | |
Dr. Brandon Lee Christianson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4601 Heritage Trace Pkwy, Fort Worth, TX 76244 Phone: 817-431-7985 Fax: 817-431-5031 | |
Stephen J White, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4601 Heritage Trace Parkway, Fort Worth, TX 76244 Phone: 817-431-7985 Fax: 817-431-5031 | |
Jesse E Smith, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 923 Pennsylvania Avenue, Suite 100, Fort Worth, TX 76104 Phone: 817-920-0484 Fax: 817-920-0068 | |
Dr. Thomas Harold Nagel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1250 8th Ave # 265, Fort Worth, TX 76104 Phone: 682-200-8580 Fax: 682-200-8581 | |
Tahir S Ali, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5801 Oakbend Trl, Suite 260, Fort Worth, TX 76132 Phone: 817-346-6000 Fax: 817-346-6009 |